- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04107597
Myofascial Trigger Point Release and Paced Breathing Training for Chronic Low Back Pain
September 26, 2019 updated by: ARCIM Institute Academic Research in Complementary and Integrative Medicine
Myofascial Trigger Point Release and Paced Breathing Training for Chronic Low Back Pain: A Randomized Controlled Trial
A study to explore whether two different treatment approaches, myofascial trigger point release and core stabilization exercises, both with and without additional paced breathing training, can help patients with chronic low back pain (CLBP) and whether one of the two treatments is superior.
Study Overview
Status
Completed
Conditions
Detailed Description
This is a randomized controlled trial to evaluate the effect of myofascial trigger point release therapy compared to core stabilization exercises, both with and without additional paced breathing training, on patients with chronic low back pain (CLBP).
The main focus is on changes in pain severity, anxiety and depression, heart rate variability, and use of analgesic medication.
Outcomes are measured at baseline (pre-intervention), after ten treatments (post-intervention), at three- and at six-month follow-up.
Study Type
Interventional
Enrollment (Actual)
124
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Baden-Württemberg
-
Filderstadt, Baden-Württemberg, Germany, 70794
- Arcim Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Written informed consent
- Age between 20 and 70 years
- LBP at least once a week during the last three months
- Pain intensity rated at least 4 on an 11-point scale (0=no pain, 10=worst pain imaginable)
- Muscular pain during flexion, extension and lateral flexion
Exclusion Criteria:
- Acute hernia
- Acute local or generalized inflammation
- Neurological disorders such as multiple sclerosis, Parkinson's disease, hemiplegia
- Fibromyalgia
- Radicular symptoms (Lasègue's sign, weakness of foot dorsiflexion muscle, needles or tingling in the legs)
- Paraspinal tumors or metastases
- Cancer under chemo- or radio-surgical treatment or requiring such during the next 12 months
- Leg prostheses
- Rheumatic, cardiovascular or chronic pulmonary condition precluding 45-minute physical therapy (contraindication declared by a physician)
- Severe depression or severe anxiety currently requiring psychotherapy and/or pharmacotherapy
- Suicidal tendencies
- Drug abuse or addiction
- Pregnancy existing or planned during the study period
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Core stabilization exercises
Patients with CLBP who practice core stabilization exercises
|
Twelve specific exercises following a standard protocol aiming at an intersegmental stabilization of the spine and strengthening and stabilization of specific muscle groups.
The exercises are performed under instruction and supervision by a physiotherapist twice per week for 45 minutes
|
Experimental: Core stabilization exercises and paced breathing training
Patients with CLBP who practice core stabilization exercises combined with paced breathing training
|
Twelve specific exercises following a standard protocol aiming at an intersegmental stabilization of the spine and strengthening and stabilization of specific muscle groups.
The exercises are performed under instruction and supervision by a physiotherapist twice per week for 45 minutes.
In addition, the participants practice paced breathing training (before and during the CSE sessions as well as 15 minutes twice per day at home) which has a modulating effect on the autonomic nervous system
|
Experimental: Myofascial trigger point release
Patients with CLBP who receive myofascial trigger point release therapy
|
A standard protocol of 12 myofascial and trigger point release grips followed by so-called roll-down maneuvers and manual rhythmical oscillation, applied to specific muscles and muscle groups.
The treatment is applied twice per week for 45 minutes
|
Experimental: Myofascial trigger point release and paced breathing training
Patients with CLBP who receive myofascial trigger point release therapy combined with paced breathing training
|
A standard protocol of 12 myofascial and trigger point release grips followed by so-called roll-down maneuvers and manual rhythmical oscillation, applied to specific muscles and muscle groups.
The treatment is applied twice per week for 45 minutes.
In addition, the participants practice paced breathing training (before and during the MTPR sessions as well as 15 minutes twice per day at home) which has a modulating effect on the autonomic nervous system
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-intervention pain severity
Time Frame: 5 weeks
|
Self-reported severity of LBP after ten treatments with the assigned intervention, assessed with the 4-item pain severity score of the Brief Pain Inventory (BPI).
The items are rated on an 11-point scale (0=no pain, 10=worst pain imaginable), the score is reported as the mean of the corresponding items.
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain severity at three-month follow-up
Time Frame: Measured at three-month follow-up
|
Self-reported severity of LBP at three-month follow-up, assessed with the 4-item pain severity score of the Brief Pain Inventory (BPI).
The items are rated on an 11-point scale (0=no pain, 10=worst pain imaginable), the score is reported as the mean of the corresponding items.
|
Measured at three-month follow-up
|
Pain severity at six-month follow-up
Time Frame: Measured at six-month follow-up
|
Self-reported severity of LBP at six-month follow-up, assessed with the 4-item pain severity score of the Brief Pain Inventory (BPI).
The items are rated on an 11-point scale (0=no pain, 10=worst pain imaginable), the score is reported as the mean of the corresponding items.
|
Measured at six-month follow-up
|
Change in pain interference
Time Frame: Measured at baseline (pre-intervention), 5 weeks (post-intervention), three- and six-month follow-up
|
Self-reported LBP-related functional impairment, assessed with the 7-item pain interference score of the Brief Pain Inventory (BPI).
The items are rated on an 11-point scale (0=no interference, 10=interferes completely), the score is reported as the mean of the corresponding items.
|
Measured at baseline (pre-intervention), 5 weeks (post-intervention), three- and six-month follow-up
|
Change in anxiety
Time Frame: Measured at baseline (pre-intervention), 5 weeks (post-intervention), three- and six-month follow-up
|
Assessed with the 7-item subscale Anxiety of the self-reporting Hospital Anxiety and Depression Scale.
The items are rated on a 4-point scale (0=positive, 3=negative) and added to a score between 0 (insignificant; non-cases) and 21 (severe)
|
Measured at baseline (pre-intervention), 5 weeks (post-intervention), three- and six-month follow-up
|
Change in depression
Time Frame: Measured at baseline (pre-intervention), 5 weeks (post-intervention), three- and six-month follow-up
|
Assessed with the 7-item subscale Depression of the self-reporting Hospital Anxiety and Depression Scale.
The items are rated on a 4-point scale (0=positive, 3=negative) and added to a score between 0 (insignificant; non-cases) and 21 (severe)
|
Measured at baseline (pre-intervention), 5 weeks (post-intervention), three- and six-month follow-up
|
Change in patients' belief in therapists' expertise
Time Frame: Measured at baseline (pre-intervention) and 5 weeks (post-intervention)
|
Assessed with the 6-item subscale "Patients' Belief in Therapists' Expertise" of the Questionnaire for Measuring Common Factors in Psychotherapy ("Fragebogen zur Erfassung relevanter Therapiebedingungen", FERT).
The items are rated on a seven-point Likert scale (1=totally disagree, 7=totally agree; score between 6 and 42).
|
Measured at baseline (pre-intervention) and 5 weeks (post-intervention)
|
Change in patients' expectation of improvement
Time Frame: Measured at baseline (pre-intervention) and 5 weeks (post-intervention)
|
Assessed with the 3-item subscale "Patients' Expectation of Improvement" of the Questionnaire for Measuring Common Factors in Psychotherapy ("Fragebogen zur Erfassung relevanter Therapiebedingungen", FERT).
The items are rated on a seven-point Likert scale (1=totally disagree, 7=totally agree; score between 3 and 21).
|
Measured at baseline (pre-intervention) and 5 weeks (post-intervention)
|
Change in therapists' expectation of improvement
Time Frame: Measured at baseline (pre-intervention) and 5 weeks (post-intervention)
|
Assessed with the 3-item scale "Therapists' Expectation of Improvement".
The items are rated on a seven-point Likert scale (1=totally disagree, 7=totally agree; score between 3 and 21).
|
Measured at baseline (pre-intervention) and 5 weeks (post-intervention)
|
HRV analysis: Change in LF/HF ratio
Time Frame: 24-hour ECG measurements taken at baseline (pre-intervention), 5 weeks (post-intervention), three- and six-month follow-up
|
LF/HF ratio = ratio of two bands from frequency domain analysis: LF band (0.04-0.15 Hz), HF band (0.15-0.40 Hz).
HRV data are obtained from 24-hour ECG measurements
|
24-hour ECG measurements taken at baseline (pre-intervention), 5 weeks (post-intervention), three- and six-month follow-up
|
HRV analysis: Change in SDNN
Time Frame: 24-hour ECG measurements taken at baseline (pre-intervention), 5 weeks (post-intervention), three- and six-month follow-up
|
Standard deviation of normal to normal (NN) intervals (ms).
HRV data are obtained from 24-hour ECG measurements
|
24-hour ECG measurements taken at baseline (pre-intervention), 5 weeks (post-intervention), three- and six-month follow-up
|
HRV analysis: Change in RMSSD
Time Frame: 24-hour ECG measurements taken at baseline (pre-intervention), 5 weeks (post-intervention), three- and six-month follow-up
|
Root mean square of successive differences (ms).
HRV data are obtained from 24-hour ECG measurements
|
24-hour ECG measurements taken at baseline (pre-intervention), 5 weeks (post-intervention), three- and six-month follow-up
|
Change in the use of analgesic medication
Time Frame: Assessed at baseline (pre-intervention), 5 weeks (post-intervention), three- and six-month follow-up
|
Amount of analgesic medication according to the medication records kept by the participants
|
Assessed at baseline (pre-intervention), 5 weeks (post-intervention), three- and six-month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2008
Primary Completion (Actual)
December 18, 2008
Study Completion (Actual)
June 12, 2009
Study Registration Dates
First Submitted
September 23, 2019
First Submitted That Met QC Criteria
September 26, 2019
First Posted (Actual)
September 27, 2019
Study Record Updates
Last Update Posted (Actual)
September 27, 2019
Last Update Submitted That Met QC Criteria
September 26, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LBP_02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Deidentified individual participant data will be made available, in addition to study protocol and informed consent form.
IPD Sharing Time Frame
The data will be made available upon publication for a duration of three months.
IPD Sharing Access Criteria
The data will be made available to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Low-back Pain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Iran University of Medical SciencesNot yet recruitingLow Back Pain | Chronic Low-back Pain | Chronic Non-specific Low Back Pain | Cupping Therapy
-
Federal University of Minas GeraisRecruitingBack Pain | Low Back Pain | Chronic Low-back Pain | Back Pain Lower Back ChronicBrazil
-
University of Colorado, BoulderNational Institutes of Health (NIH); Radiological Society of North America; Psychophysiologic... and other collaboratorsCompletedChronic Pain | Back Pain Lower Back Chronic | Back Pain, LowUnited States
-
Federal University of ParaíbaCompletedChronic Low Back Pain | Nonspecific Chronic Low Back Pain
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior CompartmentBrazil
-
Presidio Medical, IncRecruitingChronic Pain | Chronic Low-back PainAustralia
-
Spaulding Rehabilitation HospitalHighland Instruments, Inc.Active, not recruitingChronic Pain | Chronic Low Back PainUnited States
-
University of WashingtonNational Center for Complementary and Integrative Health (NCCIH)Active, not recruiting
-
Dan RhonNational Center for Complementary and Integrative Health (NCCIH); 59th Medical... and other collaboratorsRecruitingLow Back Pain | Chronic Pain | Surgery | Back Pain Lower Back Chronic | Back Pain, LowUnited States
Clinical Trials on Core stabilization exercises
-
Dow University of Health SciencesRecruiting
-
Riphah International UniversityNot yet recruitingSacroiliac Joint DysfunctionPakistan
-
Medipol UniversityActive, not recruitingSedentary Behavior | Core StabilizationTurkey
-
Bezmialem Vakif UniversityRecruitingAdolescent Idiopathic ScoliosisTurkey
-
Hacettepe UniversityCompleted
-
Riphah International UniversityCompletedPelvic Girdle PainPakistan
-
Cairo UniversityBatterjee Medical College; Taif UniversityCompletedSurgery | Bariatric SurgeryEgypt, Saudi Arabia
-
Running Injury ClinicAlberta Health services; WCB AlbertaUnknownLow Back Pain, MechanicalCanada
-
Yeditepe UniversityIstanbul UniversityCompleted
-
Bezmialem Vakif UniversityCompletedPostural Control | Hearing Disorders in Children | Respiratory Muscle Strength | Respiratory Functions | Core StabilizationTurkey